Edition:
India

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

13.75USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$13.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
295,711
52-wk High
$22.45
52-wk Low
$8.68

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.01 December 23 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 7 7 7 7
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.08 2.08 2.08 2.08

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 9 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 9 0.00 0.00 0.00 0.00
Year Ending Dec-18 10 6.22 56.25 0.00 7.44
Year Ending Dec-19 12 32.91 110.00 0.00 77.35
Earnings (per share)
Quarter Ending Jun-18 10 -1.01 -0.78 -1.30 -0.82
Quarter Ending Sep-18 10 -0.96 -0.63 -1.30 -0.76
Year Ending Dec-18 12 -3.97 -2.94 -5.18 -3.28
Year Ending Dec-19 12 -3.16 -2.18 -4.38 -2.43

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 0.00 0.94 0.94 0.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.68 0.68 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 6.22 6.22 6.22 0.69 7.44
Year Ending Dec-19 32.91 32.91 32.91 32.39 77.35

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings